Your browser doesn't support javascript.
loading
Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma.
Chavez, Julio C; Foss, Francine M; William, Basem M; Brammer, Jonathan E; Smith, Sonali M; Prica, Anca; Zain, Jasmine M; Tuscano, Joseph M; Shah, Harsh; Mehta-Shah, Neha; Geethakumari, Praveen Ramakrishnan; Wang, Ben X; Zantinge, Stephanie; Wang, Lisa; Zhang, Ling; Boutrin, Anmarie; Zhao, Weiguang; Cheng, Lily; Standifer, Nathan; Hewitt, Lisa; Enowtambong, Enowmpey; Shao, Weiping; Sharma, Shringi; Carlesso, Gianluca; Moscow, Jeffrey A; Siu, Lillian L.
Afiliación
  • Chavez JC; Moffitt Cancer Center, Tampa, Florida.
  • Foss FM; Hematology, Yale Cancer Center, New Haven, Connecticut.
  • William BM; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Brammer JE; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Smith SM; University of Chicago, Chicago, Illinois.
  • Prica A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Zain JM; City of Hope Comprehensive Cancer Center, Duarte, California.
  • Tuscano JM; UC Davis Cancer Center, Sacramento, California.
  • Shah H; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
  • Mehta-Shah N; Siteman Cancer Center, Washington University, St. Louis, Missouri.
  • Geethakumari PR; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.
  • Wang BX; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Zantinge S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Wang L; Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Zhang L; Department of Hematopathology, Moffitt Cancer Center, Tampa, Florida.
  • Boutrin A; US Imaging Hub, Clinical Pharmacology and Safety Sciences, AstraZeneca, Gaithersburg, Maryland.
  • Zhao W; US Imaging Hub, Clinical Pharmacology and Safety Sciences, AstraZeneca, Gaithersburg, Maryland.
  • Cheng L; Oncology Safety/Pathology, Clinical Pharmacology and Safety Sciences, AstraZeneca, Gaithersburg, Maryland.
  • Standifer N; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, South San Francisco, California.
  • Hewitt L; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland.
  • Enowtambong E; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland.
  • Shao W; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland.
  • Sharma S; Quantitative Clinical Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, South San Francisco, California.
  • Carlesso G; Early Oncology Discovery, Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland.
  • Moscow JA; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland.
  • Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Clin Cancer Res ; 29(10): 1869-1878, 2023 05 15.
Article en En | MEDLINE | ID: mdl-36826995

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células T / Linfoma de Células T Periférico Límite: Aged / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células T / Linfoma de Células T Periférico Límite: Aged / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article